Advertisement

Topics

Latest "Zenith Administrators" News Stories

13:39 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "Zenith Administrators" found in our extensive news archives from over 250 global news sources.

More Information about Zenith Administrators on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Zenith Administrators for you to read. Along with our medical data and news we also list Zenith Administrators Clinical Trials, which are updated daily. BioPortfolio also has a large database of Zenith Administrators Companies for you to search.

Showing "Zenith Administrators" News Articles 1–25 of 299

Relevant

Zenith experiences growth due to demand for technology

Global life sciences technology firm, Zenith Technologies, has expanded its workforce in response to the increase in demand for its manufacturing execution system (MES) and automation technology.


10 health systems seeking cardiology administrators

Cardiology administrators have important work ahead of them as practice

BioCryst to evaluate BCX7353 for hereditary angioedema attacks

BioCryst Pharmaceuticals announced the dosing of the first subject into ZENITH-1, a clinical trial studying up to three dosage strengths of a liquid formulation of BCX7353 given as a single oral dose for the acute treatment of angioedema attacks in patients with hereditary angioedema (HAE). “We are excited to launch the ZENITH-1 exploratory phase II […] The post BioCryst to evaluate BC...


ASCRS, ASOA representatives meet with Congress members at annual fly-in

About 50 physicians and ophthalmic administrators representing the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators met with members of Congress in Washington to discuss the need to repeal the Independent Payment Advisory Board and the need for regulatory relief for physicians and other care providers from several specific program requiremen...

Zenith Announces Annual General Meeting of Shareholders

CALGARY, Alberta, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) announced today that its Annual Meeting of Shareholders (the “Meeting”) is to be held Tuesday, December 12, 2017 at Mount Royal University, Ross Glenn Hall (Room EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta, commencing at 2:45 pm (MT). A Notice of Meeting and Management In...

Zenith Announces Webcast Presentation at the BIO Investor Forum in San Francisco, CA

CALGARY, Alberta, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces its participation in the upcoming BIO Investor Forum in San Francisco, CA. Mr. Donald J. McCaffrey, President and Chief Executive Officer, will provide a corporate update and overview of recent activities at the conference. Presentation & Webcast Details: Date: T...

Cook Medical Recalls Select Zenith Alpha Thoracic Endovascular Grafts

  Life Sciences Jobs   ...

Zenith Technologies Release: Research Reveals Costly Implementation Is The Biggest Barrier To Serialization Compliance

  Life Sciences Jobs   ...

Cook Medical Recalls Zenith Alpha Thoracic Endovascular Grafts and Removes Specific Sizes From the Market

  Life Sciences Jobs   ...

Biocryst Announces Initiation Of ZENITH-1, A Clinical Trial To Evaluate BCX7353 As An Acute Treatment Of Hereditary Angioedema Attacks

  Life Sciences Jobs   ...

Corista to Present on AI and Leveraging Emerging Technology at Southeast Pathology Chairs & Administrators Conference (SEAPC)

Concord, MA (PRWEB) October 11, 2017 Dr. Keith Kaplan, Corista Chief Medical Officer, and Eric Wirch, Corista Chief Technology Officer and Managing Director, will present at the Southeast Pathology Chairs & Administrators Conference this fall. Their presentation will focus on advancements...

The Business Benefits of Transitioning to MES Technology

ArticleHow migrating to MES technology can help companies optimize their performance and how implementing a support model can maximize investment.

The Biggest Barrier to Serialization Compliance? Implementation Cost

NewsResearch reveals costly implementation is the biggest barrier to serialization compliance.

How to Effectively Boost Hand-washing Compliance

Administrators at Henry Ford Hospital regularly use "mystery observers" in the ED to check up on how compliant clinicians and staff are.

First patient receives BCX7353 dosing in BioCryst’s Phase II trial for HAE

US-based BioCryst Pharmaceuticals has started dosing patients in the Phase II ZENITH-1 exploratory clinical trial of BCX7353 to treat patients with hereditary angioedema (HAE).

Cook Medical Issues Recall Correction of Zenith Alpha™ Thoracic Endovascular Graft and Removes Specific Sizes from the Market

On June 22, 2017, Cook Medical initiated a correction to the Instructions For Use (IFU) for the Zenith Alpha™ Thoracic Endovascular Graft. This correction removed the indication for blunt thoracic aortic injury, also known as BTAI or “transection” of the aorta, because Cook has received an increase in reports of graft thrombosis and occlusion with th...

Bain Capital Private Equity makes offer for Zenith Hygiene Group plc to expand Diversey in Europe

Bain Capital Private Equity, a leading global private investment firm, today announced it has, through its investment in Diversey, reached agreement on the terms of a recommended final* cash offer for Zenith Hygiene Group plc, a UK manufacturer of cleaning and hygiene chemicals and related products. Based in Hertfordshire, Zenith Hygiene offers a ...

Probably Relevant

Our noble profession is being destroyed by legislators and administrators

I had a great day in the office today. Not that I came up with any brilliant diagnosis nor cured anyone. I was able to just be a physician. No time wasted on the phone with insurance companies. No prior authorizations to do. It was a reminder of how much I love my job. I […]

Some Physicians Who Were Initially Skeptical Of Bundled-Payment Program Coming Around

Administrators and physicians say they're impressed with how the programs have engaged physicians to produce lower costs and better outcomes.

Recall of Cook Medical's thoracic endovascular graft labeled Class I by FDA

A recall initiated by Cook Medical involving its Zenith Alpha thoracic endovascular graft was classified by the FDA as Class  -More- 

What Administrators Need to Know about Imaging Informatics

A high-level overview of imaging informatics for the radiology administrator, from AHRA 2017.

Cook Removes Indication, Pulls Sizes From Market Following Graft Recall

Cook Medical is pulling certain sizes of its Zenith Alpha thoracic endovascular graft from the market due to reports blood...    

How Colleges Are Reacting to the Opioid Crisis

The deadly opioid epidemic sweeping the country has largely spared college campuses, but drug abuse experts warn administrators they should be paying closer attention.

CannaRoyalty Welcomes Favourable TMX Group Update Regarding Issuers with U.S. ...

TMX Group confirms it will rely on the Canadian Securities Administrators' recommendation to defer to individual exchange's rules OTTAWA, ONTARIO--(Marketwired - Nov. 24, 2017) - Read more...

ADDING MULTIMEDIA Cook Medical Issues Recall Correction of Zenith Alpha™ Thoracic Endovascular Graft and Removes Specific Sizes from the Market

On June 22, 2017, Cook Medical initiated a correction to the Instructions For Use (IFU) for the Zenith Alpha™ Thoracic Endovascular Graft. This correction removed the indication for blunt thoracic aortic injury, also known as BTAI or “transection” of the aorta, because Cook has received an increase in reports of graft thrombosis and occlusion with th...


Quick Search
Advertisement
 

News Quicklinks